123 related articles for article (PubMed ID: 37633117)
1. Non-classical circulating monocytes expressing high levels of microsomal prostaglandin E2 synthase-1 tag an aberrant IFN-response in systemic sclerosis.
Villanueva-Martin G; Acosta-Herrera M; Carmona EG; Kerick M; Ortego-Centeno N; Callejas-Rubio JL; Mages N; Klages S; Börno S; Timmermann B; Bossini-Castillo L; Martin J
J Autoimmun; 2023 Nov; 140():103097. PubMed ID: 37633117
[TBL] [Abstract][Full Text] [Related]
2. Elevated Fibronectin Levels in Profibrotic CD14
Rudnik M; Hukara A; Kocherova I; Jordan S; Schniering J; Milleret V; Ehrbar M; Klingel K; Feghali-Bostwick C; Distler O; Błyszczuk P; Kania G
Front Immunol; 2021; 12():642891. PubMed ID: 34504485
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus lytic infection promotes activation of Toll-like receptor 8 innate immune response in systemic sclerosis monocytes.
Farina A; Peruzzi G; Lacconi V; Lenna S; Quarta S; Rosato E; Vestri AR; York M; Dreyfus DH; Faggioni A; Morrone S; Trojanowska M; Farina GA
Arthritis Res Ther; 2017 Feb; 19(1):39. PubMed ID: 28245863
[TBL] [Abstract][Full Text] [Related]
4. A macrophage marker, Siglec-1, is increased on circulating monocytes in patients with systemic sclerosis and induced by type I interferons and toll-like receptor agonists.
York MR; Nagai T; Mangini AJ; Lemaire R; van Seventer JM; Lafyatis R
Arthritis Rheum; 2007 Mar; 56(3):1010-20. PubMed ID: 17328080
[TBL] [Abstract][Full Text] [Related]
5. Versican is upregulated in circulating monocytes in patients with systemic sclerosis and amplifies a CCL2-mediated pathogenic loop.
Masuda A; Yasuoka H; Satoh T; Okazaki Y; Yamaguchi Y; Kuwana M
Arthritis Res Ther; 2013 Jul; 15(4):R74. PubMed ID: 23845159
[TBL] [Abstract][Full Text] [Related]
6. Integrated bulk and single-cell RNA-sequencing identified disease-relevant monocytes and a gene network module underlying systemic sclerosis.
Kobayashi S; Nagafuchi Y; Okubo M; Sugimori Y; Shirai H; Hatano H; Junko M; Yanaoka H; Takeshima Y; Ota M; Iwasaki Y; Sumitomo S; Okamura T; Yamamoto K; Shoda H; Fujio K
J Autoimmun; 2021 Jan; 116():102547. PubMed ID: 33039247
[TBL] [Abstract][Full Text] [Related]
7. Characterization of monocyte/macrophage subsets in the skin and peripheral blood derived from patients with systemic sclerosis.
Higashi-Kuwata N; Jinnin M; Makino T; Fukushima S; Inoue Y; Muchemwa FC; Yonemura Y; Komohara Y; Takeya M; Mitsuya H; Ihn H
Arthritis Res Ther; 2010; 12(4):R128. PubMed ID: 20602758
[TBL] [Abstract][Full Text] [Related]
8. Increased frequencies of circulating CXCL10-, CXCL8- and CCL4-producing monocytes and Siglec-3-expressing myeloid dendritic cells in systemic sclerosis patients.
Carvalheiro T; Horta S; van Roon JAG; Santiago M; Salvador MJ; Trindade H; Radstake TRDJ; da Silva JAP; Paiva A
Inflamm Res; 2018 Feb; 67(2):169-177. PubMed ID: 29127442
[TBL] [Abstract][Full Text] [Related]
9. Regulation of Monocyte Adhesion and Type I Interferon Signaling by CD52 in Patients With Systemic Sclerosis.
Rudnik M; Rolski F; Jordan S; Mertelj T; Stellato M; Distler O; Blyszczuk P; Kania G
Arthritis Rheumatol; 2021 Sep; 73(9):1720-1730. PubMed ID: 33760395
[TBL] [Abstract][Full Text] [Related]
10. Disparate Interferon Signaling and Shared Aberrant Basaloid Cells in Single-Cell Profiling of Idiopathic Pulmonary Fibrosis and Systemic Sclerosis-Associated Interstitial Lung Disease.
Valenzi E; Tabib T; Papazoglou A; Sembrat J; Trejo Bittar HE; Rojas M; Lafyatis R
Front Immunol; 2021; 12():595811. PubMed ID: 33859634
[TBL] [Abstract][Full Text] [Related]
11. A circulating cell population showing both M1 and M2 monocyte/macrophage surface markers characterizes systemic sclerosis patients with lung involvement.
Trombetta AC; Soldano S; Contini P; Tomatis V; Ruaro B; Paolino S; Brizzolara R; Montagna P; Sulli A; Pizzorni C; Smith V; Cutolo M
Respir Res; 2018 Sep; 19(1):186. PubMed ID: 30249259
[TBL] [Abstract][Full Text] [Related]
12. Characterization of Long Non-Coding RNAs in Systemic Sclerosis Monocytes: A Potential Role for PSMB8-AS1 in Altered Cytokine Secretion.
Servaas NH; Mariotti B; van der Kroef M; Wichers CGK; Pandit A; Bazzoni F; Radstake TRDJ; Rossato M
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33922041
[TBL] [Abstract][Full Text] [Related]
13. Histone modifications underlie monocyte dysregulation in patients with systemic sclerosis, underlining the treatment potential of epigenetic targeting.
van der Kroef M; Castellucci M; Mokry M; Cossu M; Garonzi M; Bossini-Castillo LM; Chouri E; Wichers CGK; Beretta L; Trombetta E; Silva-Cardoso S; Vazirpanah N; Carvalheiro T; Angiolilli C; Bekker CPJ; Affandi AJ; Reedquist KA; Bonte-Mineur F; Zirkzee EJM; Bazzoni F; Radstake TRDJ; Rossato M
Ann Rheum Dis; 2019 Apr; 78(4):529-538. PubMed ID: 30793699
[TBL] [Abstract][Full Text] [Related]
14. The interferon type I signature is present in systemic sclerosis before overt fibrosis and might contribute to its pathogenesis through high BAFF gene expression and high collagen synthesis.
Brkic Z; van Bon L; Cossu M; van Helden-Meeuwsen CG; Vonk MC; Knaapen H; van den Berg W; Dalm VA; Van Daele PL; Severino A; Maria NI; Guillen S; Dik WA; Beretta L; Versnel MA; Radstake T
Ann Rheum Dis; 2016 Aug; 75(8):1567-73. PubMed ID: 26371289
[TBL] [Abstract][Full Text] [Related]
15. The Long Non-coding RNA NRIR Drives IFN-Response in Monocytes: Implication for Systemic Sclerosis.
Mariotti B; Servaas NH; Rossato M; Tamassia N; Cassatella MA; Cossu M; Beretta L; van der Kroef M; Radstake TRDJ; Bazzoni F
Front Immunol; 2019; 10():100. PubMed ID: 30804934
[TBL] [Abstract][Full Text] [Related]
16. Circulating monocytes from systemic sclerosis patients with interstitial lung disease show an enhanced profibrotic phenotype.
Mathai SK; Gulati M; Peng X; Russell TR; Shaw AC; Rubinowitz AN; Murray LA; Siner JM; Antin-Ozerkis DE; Montgomery RR; Reilkoff RA; Bucala RJ; Herzog EL
Lab Invest; 2010 Jun; 90(6):812-23. PubMed ID: 20404807
[TBL] [Abstract][Full Text] [Related]
17. Downregulated IRF8 in Monocytes and Macrophages of Patients with Systemic Sclerosis May Aggravate the Fibrotic Phenotype.
Ototake Y; Yamaguchi Y; Asami M; Komitsu N; Akita A; Watanabe T; Kanaoka M; Kurotaki D; Tamura T; Aihara M
J Invest Dermatol; 2021 Aug; 141(8):1954-1963. PubMed ID: 33705797
[TBL] [Abstract][Full Text] [Related]
18. Differentiation potential of CD14+ monocytes into myofibroblasts in patients with systemic sclerosis.
Binai N; O'Reilly S; Griffiths B; van Laar JM; Hügle T
PLoS One; 2012; 7(3):e33508. PubMed ID: 22432031
[TBL] [Abstract][Full Text] [Related]
19. Peripheral cells from patients with systemic sclerosis disease co-expressing M1 and M2 monocyte/macrophage surface markers: Relation to the degree of skin involvement.
Mohamed ME; Gamal RM; El-Mokhtar MA; Hassan AT; Abozaid HSM; Ghandour AM; Abdelmoez A Ismail S; A Yousef H; H El-Hakeim E; S Makarem Y; Abdellatif Awad A
Hum Immunol; 2021 Sep; 82(9):634-639. PubMed ID: 34020830
[TBL] [Abstract][Full Text] [Related]
20. Profibrotic Activation of Human Macrophages in Systemic Sclerosis.
Bhandari R; Ball MS; Martyanov V; Popovich D; Schaafsma E; Han S; ElTanbouly M; Orzechowski NM; Carns M; Arroyo E; Aren K; Hinchcliff M; Whitfield ML; Pioli PA
Arthritis Rheumatol; 2020 Jul; 72(7):1160-1169. PubMed ID: 32134204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]